Learn about CVE-2023-30561 impacting BD Alaris™ Point-of-Care Unit (PCU) Model 8015. Understand the vulnerability, its impact, and mitigation strategies to protect sensitive data.
This article provides detailed information about CVE-2023-30561, a vulnerability affecting the BD Alaris™ Point-of-Care Unit (PCU) Model 8015, allowing threat actors to read or modify data with physical access.
Understanding CVE-2023-30561
This section delves into the specifics of the CVE-2023-30561 vulnerability, its impact, technical details, and mitigation strategies.
What is CVE-2023-30561?
The vulnerability involves insecure data transmission between the PCU and its modules, enabling a threat actor with physical access to potentially read or modify data by attaching a specially crafted device during an infusion.
The Impact of CVE-2023-30561
CVE-2023-30561 has a base severity of MEDIUM with a CVSS base score of 6.1. It falls under CAPEC-390 (Bypassing Physical Security) and CAPEC-94 (Man in the Middle Attack), posing a threat to the confidentiality and availability of sensitive data.
Technical Details of CVE-2023-30561
This section provides a deeper insight into the vulnerability description, affected systems, and exploitation mechanism.
Vulnerability Description
The lack of cryptographic security in the IUI Bus of BD Alaris™ Point-of-Care Unit (PCU) Model 8015 allows unauthorized access to sensitive data during infusions, potentially leading to data manipulation.
Affected Systems and Versions
The vulnerability affects BD Alaris™ Point-of-Care Unit (PCU) Model 8015 with versions up to 12.1.3.
Exploitation Mechanism
A threat actor can exploit the vulnerability by attaching a specially crafted device to the IUI Bus during an infusion, bypassing physical security measures and intercepting/modifying data.
Mitigation and Prevention
This section outlines immediate steps to take and long-term security practices to mitigate the risks associated with CVE-2023-30561.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates